BioSenic puts Phase IIb ALLOB trial on hold.
BioSenic puts Phase IIb ALLOB trial on hold.
Mont Saint Guibert Waals Gewest France General Lieven Huysse Euronext Brussels Chief Medical Officer
Source: pharmiweb.com
📰 Per Protocol News
Page 2 - Per Protocol News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Per Protocol. Real-time updates on events, politics, business and more.
Gut-heart axis polyphenol-rich extracts can modulate gut microbiota
A clinical trial found that supplementation with a water-soluble tomato concentrate decreases fasting blood and urine TMAO conferring the host a cardiovascular health benefit.
Source: nutraingredients.com
FOXNEWS Hannity June 4, 2024 06:09:00
D.a.? >> not yet, no. you know, they say thatly notify us when theres a grand jury vote. when that happens, depending on that vote, the next steps will be discussed. were hearing what everyone else is hearing regarding timing and whatnot. >> sean: the grand jury convenes tomorrow at 2:00 p.m. probably be done by 5:00 p.m. that would be the earliest you would hear from them. i assume protocol, you hear from them first, correct? >> per protocol. not a lot about this case is following protocol. nor...
Source: archive.org
FOXNEWS Hannity June 4, 2024 01:09:00
>> not yet, no. you know, they say thatly notify us when theres a grand jury vote. when that happens, depending on that vote, the next steps will be discussed. were hearing what everyone else is hearing regarding timing and whatnot. >> sean: the grand jury convenes tomorrow at 2:00 p.m. probably be done by 5:00 p.m. that would be the earliest you would hear from them. i assume protocol, you hear from them first, correct? >> per protocol. not a lot about this case is following protocol. normally ...
Source: archive.org
Biophytis Announces Positive Final Results of the Phase 2-3 COVA Study with Sarconeos in Severe COVID-19
COVA study met primary end point with 44% significant reduction in the risk of respiratory failure or early deathFiling for Early Access Programs to Sarconeos (BIO101) is being initated while preparing
Source: finanznachrichten.de
Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19
Biophytis / Key word(s): Miscellaneous Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO1...
Source: businessinsider.com
Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) i
Biophytis / Key word(s): Miscellaneous Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 02-Feb-2023 / 08:00 CET/CEST Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19   C...
Source: pharmiweb.com
Investegate |Synairgen plc Announcements | Synairgen plc: SPRINTER Trial Results Published
Investegate announcements from Synairgen plc, SPRINTER Trial Results Published
Source: investegate.co.uk
Biophytis Organises a Webcast with Key Opinion Leaders On the Phase 2-3 Cova Study Results of Sarconeos In the Treatment of Pneumonia in Covid-19 Patients at Risk of Respiratory Failure
Following the positive post-hoc analysis of the phase 2-3 COVA clinical study strongly supporting therapeutic potential of Sarconeos (BIO101) in the treatment of pneumonia in COVID-19 patients at risk
Source: finanznachrichten.de
BIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LEADERS (KOL) ON THE PHASE 2-3 COVA STUDY RESULTS OF
Biophytis / Key word(s): MiscellaneousBIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LEADERS (KOL) ON THE PHASE 2-3 COVA STUDY RESULTS OF SARCONEOS (BIO101) IN THE TREATMENT OF PNEUMONIA IN COVID-19 PATIENTS AT RISK OF RESPIRAT 01-Dec-2022 / 08:07 CET/CEST  BIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LE...
Source: pharmiweb.com